Northwest Arkansas Clinical Trials Center has been a dedicated dermatology research center for more than 7 years. The research center is located in the heart of Northwest Arkansas, home to a regional population of more than 500,000 residents and two large college campuses. The clinical trials center has over 1500 square feet solely dedicated to dermatology research and research subjects. The center includes a reception area, examination rooms, laboratory, locked and temperature monitored investigational product ambient storage, study coordinator offices, and temperature monitored refrigerator and -20 C freezer. All equipment undergoes certification annually.
The combined clinical trial team experience in phase I-phase IV studies exceeds 50 years. Investigational product formulation experience includes oral, intravenous, topical and other parenteral routes. All personnel have certified GCP training and most are IATA certified. The staff is very familiar with the variety of electronic data capture (EDC) platforms and are very proficient in data entry.
The center and personnel have clinical trial experience in the following dermatologic conditions in pediatric, adolescent and adult populations:
- Atopic Dermatitis
- Common Warts
- Seborrheic Keratosis
- Hidradenitis suppurativa
Botulinum toxin therapy: Overview
Also called botulinum rejuvenation
Brand names: Botox® Cosmetic, Dysport®, MYOBLOC®, and XEOMIN®
When you look in the mirror, do you see deep frown lines? These lines bother many people.
To diminish these lines , many choose botulinum toxin therapy. Patients like that they can return to most everyday activities immediately after the procedure. They like that most people see results within 3 to 7 days.
A dermatologist can perform the treatment during a single office visit. The improvements last about 3 to 4 months — and sometimes longer.
Uses: Dermatologists use botulinum toxin therapy to diminish signs of aging and to treat a medical condition called hyperhidrosis (excessive sweating). Botulinum toxin therapy is approved by the U.S. Food and Drug Administration (FDA) to treat the following dermatologic conditions:
- Frown lines between the eyebrows.
- Crow's feet.
- Excessive sweating in the underarms when treatment applied to the skin does not work well enough.
Insurance coverage: This varies with insurance plans. In general, you can expect:
- Signs of aging are not covered.
- Excessive sweating may be covered, at least partly. You should contact your insurance company to find out what your policy covers.
Images used with permission of the Journal of the American Academy of Dermatology. Ascher B, Zakine B, et al. “A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.” J Am Acad Dermatol. 2004;51:223-233.